263 related articles for article (PubMed ID: 27207165)
1. Regulatory approval of new medical devices: cross sectional study.
Marcus HJ; Payne CJ; Hughes-Hallett A; Marcus AP; Yang GZ; Darzi A; Nandi D
BMJ; 2016 May; 353():i2587. PubMed ID: 27207165
[TBL] [Abstract][Full Text] [Related]
2. Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications.
Lee SJ; Cho L; Klang E; Wall J; Rensi S; Glicksberg BS
JAMA Netw Open; 2021 Jun; 4(6):e2112562. PubMed ID: 34156454
[TBL] [Abstract][Full Text] [Related]
3. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
[TBL] [Abstract][Full Text] [Related]
4. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
Dubin JR; Simon SD; Norrell K; Perera J; Gowen J; Cil A
JAMA Netw Open; 2021 May; 4(5):e217274. PubMed ID: 33956132
[TBL] [Abstract][Full Text] [Related]
5. New orthopedic devices and the FDA.
Sheth U; Nguyen NA; Gaines S; Bhandari M; Mehlman CT; Klein G
J Long Term Eff Med Implants; 2009; 19(3):173-84. PubMed ID: 20939777
[TBL] [Abstract][Full Text] [Related]
6. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
Samuel AM; Rathi VK; Grauer JN; Ross JS
Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
[TBL] [Abstract][Full Text] [Related]
7. Regulatory aspects of invasive glucose measurements.
Gutman S; Bernhardt P; Pinkos A; Moxey-Mims M; Knott T; Cooper J
Diabetes Technol Ther; 2002; 4(6):775-7. PubMed ID: 12685800
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
Rathi VK; Krumholz HM; Masoudi FA; Ross JS
JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
[TBL] [Abstract][Full Text] [Related]
9. [Comments and suggestions on the medical device standardization system from the view point of medical devices test].
Yang X; Wang C; Yang Z; Li D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Jun; 30(3):546-51. PubMed ID: 23865316
[TBL] [Abstract][Full Text] [Related]
10. FDA Regulation and Approval of Medical Devices: 1976-2020.
Darrow JJ; Avorn J; Kesselheim AS
JAMA; 2021 Aug; 326(5):420-432. PubMed ID: 34342614
[TBL] [Abstract][Full Text] [Related]
11. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
[TBL] [Abstract][Full Text] [Related]
12. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.
Chang L; Dhruva SS; Chu J; Bero LA; Redberg RF
BMJ; 2015 Jun; 350():h2613. PubMed ID: 26063311
[TBL] [Abstract][Full Text] [Related]
13. Regulation and Device Development: Tips for Optimizing Your Experience With the Food and Drug Administration.
Brooks SS
Tech Vasc Interv Radiol; 2017 Jun; 20(2):109-115. PubMed ID: 28673647
[TBL] [Abstract][Full Text] [Related]
14. Regulation of medical devices in the European Union.
Chai J
J Leg Med; 2000 Dec; 21(4):537-56. PubMed ID: 11194571
[No Abstract] [Full Text] [Related]
15. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
[TBL] [Abstract][Full Text] [Related]
16. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
Corcoran Ruiz KM; Vaishnav YJ; Desautels J; Schaefer JL; Migliori ME; Yilmaz T
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):503-506. PubMed ID: 35699217
[TBL] [Abstract][Full Text] [Related]
17. Medical devices: US medical device regulation.
Jarow JP; Baxley JH
Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceuticals and medical devices: medical devices. Year end issue brief.
Tiffany S
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-19. PubMed ID: 18345548
[No Abstract] [Full Text] [Related]
19. Transparency and Dermatologic Device Approval by the US Food and Drug Administration.
Ezaldein HH; Scott JF; Yin ES; Ventura A; DeRuyter NP; Leffell DJ
JAMA Dermatol; 2018 Mar; 154(3):273-280. PubMed ID: 29365020
[TBL] [Abstract][Full Text] [Related]
20. Premarket evaluation of medical devices: a cross-sectional analysis of clinical studies submitted to a German ethics committee.
Sauerland S; Fujita-Rohwerder N; Zens Y; Molnar S
BMJ Open; 2019 Feb; 9(2):e027041. PubMed ID: 30798319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
